20951-43-3Relevant articles and documents
PROCESS FOR THE PREPARATION OF BROMODOMAIN INHIBITOR
-
Paragraph 0217-0218; 0224-0225; 0027-0228; 0267-0272, (2020/02/17)
The present invention provides processes of synthesis and purification of a bromodomain inhibitor, Compound 1, which compound includes crystalline forms, amorphous forms, solvates, and hydrates thereof. Embodiments of the disclosure relate to chemical syn
BROMODOMAIN AND EXTRA-TERMINAL PROTEIN INHIBITOR COMBINATION THERAPY
-
Paragraph 0140, (2017/07/14)
The present disclosure relates generally to compositions and methods of treating cancers, such as glioblastoma and non-Hodgkin's lymphomas, or other cancers in which the subject suffers from an advanced solid tumor, comprising the administration of a brom
Biaryl-propionic acid derivatives and their use as pharmaceuticals
-
Paragraph 0190; 0191, (2014/10/16)
The present invention relates to compounds of the formula I, wherein X, R, R1, R2, D, E1, E2, E3, E4, G1, G2, G3 and G4 have the meanings indicated in the claims, which are valuable pharmaceutical active compounds. They are inhibitors of the protease cath